NCT02512250

Brief Summary

The Swiss Hemophilia Registry will collect data on the prophylactic and therapeutic use of factor concentrates in patients with hemophilia and other severe bleeding disorders in Switzerland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2015

Longer than P75 for all trials

Geographic Reach
1 country

19 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 26, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 30, 2015

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

October 27, 2022

Status Verified

October 1, 2022

Enrollment Period

10.6 years

First QC Date

July 26, 2015

Last Update Submit

October 25, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of incidence of disease and inhibitor development

    Demographics, Comorbidties, factor consumption for prophylaxis, bleeding and surgery, inhibito develeopment

    1 year

Interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hemophilia and other severe bleeding disorders

You may qualify if:

  • Diagnosis of hemophilia or other severe bleeding disorders. Signed inform consent

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Kantonsspital Aarau Zentrum für Onkologie/Hämatologie und Transfusionsmedizin

Aarau, 5001, Switzerland

RECRUITING

Kinderklinik

Aarau, 5001, Switzerland

RECRUITING

Universitätsspital Basel Diagnostische Hämatologie

Basel, 4031, Switzerland

RECRUITING

Universitätskinderspital beider Basel (UKBB) Abteilung Onkologie/Hämatologie

Basel, 4056, Switzerland

RECRUITING

Ospedale San Giovanni

Bellinzona, 6500, Switzerland

RECRUITING

Servizio di Ematologia Ospedale Regionale di Bellinzona e Valli

Bellinzona, 6500, Switzerland

RECRUITING

Inselspital, Universitätsspital Bern Poliklinik für Hämatologie

Bern, 3010, Switzerland

RECRUITING

Kantonspital Graubünden

Chur, 7000, Switzerland

RECRUITING

Unité d'Hémostase HUG

Geneva, 1211, Switzerland

RECRUITING

Unité d'Oncologie-Hématologie pédiatrique, Hôpital des Enfants HUG

Geneva, 1211, Switzerland

RECRUITING

Centre Hospitalier Universitaire Vaudois Service d'Hématologie

Lausanne, 1011, Switzerland

RECRUITING

Policlinique d'onco-hématologie péd., CHUV

Lausanne, 1011, Switzerland

RECRUITING

Kantonsspital Luzern Abteilung Hämatologie

Lucerne, 6000, Switzerland

RECRUITING

Kinderspital Luzern

Lucerne, 6000, Switzerland

RECRUITING

Ostschweizer Kinderspital St. Gallen

Sankt Gallen, 9006, Switzerland

RECRUITING

Kantonspital St. Gallen

Sankt Gallen, 9007, Switzerland

RECRUITING

Kinder und Erwachsenenzentrum Sion Service Régional Valaisan de Transfusion Sanguine CRS

Sion, 1950, Switzerland

NOT YET RECRUITING

University Children's Hospital

Zurich, 8032, Switzerland

RECRUITING

University Hospital Zürich

Zurich, 8090, Switzerland

RECRUITING

MeSH Terms

Conditions

Hemophilia A

Interventions

Registries

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesRecordsOrganization and AdministrationHealth Services AdministrationHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2015

First Posted

July 30, 2015

Study Start

May 1, 2015

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

October 27, 2022

Record last verified: 2022-10

Locations